Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.


The use of angiotensin-converting enzyme inhibitors during pregnancy has been associated with poor fetal outcomes, including oligohydramnios, renal tubular dysplasia, cranial malformations, and fetal death. A 35-year-old woman with chronic hypertension was treated with the angiotensin-converting enzyme inhibitor benazepril until 27 weeks' gestation, when… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.